Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease. | J Exp Med | 2021 | 33831141 | PubTator, text mining | PubMed |
| Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients. | Leukemia | 2021 | 33820961 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma: new targets and novel therapies. | Blood Cancer J | 2021 | 33820908 | PubTator, text mining | PubMed |
| Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study. | Aging (Albany NY) | 2021 | 33820874 | PubTator, text mining | PubMed |
| Autoimmune Complications in Hematologic Neoplasms. | Cancers (Basel) | 2021 | 33810369 | PubTator, text mining | PubMed |
| Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario. | Curr Oncol | 2021 | 33808300 | PubTator, text mining | PubMed |
| Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia. | J Pers Med | 2021 | 33808164 | PubTator, text mining | PubMed |
| Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas. | Cells | 2021 | 33803671 | PubTator, text mining | PubMed |
| A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research. | Int J Mol Sci | 2021 | 33802234 | PubTator, text mining | PubMed |
| The evolving role of Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia. | Ther Adv Hematol | 2021 | 33796237 | PubTator, text mining | PubMed |
| mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies. | Commun Biol | 2021 | 33782531 | PubTator, text mining | PubMed |
| A Major Subset of Mutated CLL Expresses Affinity-selected and Functionally Proficient Rheumatoid Factors. | Hemasphere | 2021 | 33778415 | PubTator, text mining | PubMed |
| Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: Implications for advanced antibody design. | Comput Struct Biotechnol J | 2021 | 33777333 | PubTator, text mining | PubMed |
| The antigenic anatomy of SARS-CoV-2 receptor binding domain. | Cell | 2021 | 33756110 | PubTator, text mining | PubMed |
| Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection. | Cell Rep Med | 2021 | 33748788 | PubTator, text mining | PubMed |
| STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells. | Oncotarget | 2021 | 33747356 | PubTator, text mining | PubMed |
| A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes. | Nat Commun | 2021 | 33741942 | PubTator, text mining | PubMed |
| Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. | Hematol Oncol | 2021 | 33739461 | PubTator, text mining | PubMed |
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma. | Leuk Lymphoma | 2021 | 33734005 | PubTator, text mining | PubMed |
| In vivo, ex vivo and in vitro dasatinib activity in chronic lymphocytic leukemia. | Oncol Lett | 2021 | 33732361 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=48